by Elena Iemma | Jul 17, 2025 | Blog
Tregs, Epitopes, and the Future of Immune Tolerance Making Sense of Natural Constraint Contrary to popular (immunologist) belief, there’s nothing ‘non-specific’ about Tregs! Otherwise why would they carry TCR (T cell receptors) that bind to their...
by Elena Iemma | Apr 21, 2025 | News
The Role of Treg Epitopes (Tregitopes) in Antibody Maturation Uncovered in New EpiVax Study: Implications for Therapeutic Antibodies PROVIDENCE, R.I., April 21, 2025 /PRNewswire/ — EpiVax, Inc. announces a new study published in Frontiers in Immunology unveiling...
by Elena Iemma | May 12, 2024 | Blog
The Time is Now for Tregs! I spoke at a conference on Treg-directed therapies this week and wow! Things are happening in Tregitopia! There were lots of fancy companies (e.g. Jeff Bluestone’s Sonoma featuring products named after grapes) aiming to use CAR-T-like...
by Elena Iemma | Apr 4, 2023 | Events
Thank you to everyone who participated in the 9th annual Amsterdam Immunogenicity and Tolerance Seminar! The day would not have been such a success without you. Check out these photos from the event. A special thanks to the Seminar organizing committee: Corine...
by Elena Iemma | Jul 4, 2022 | Events
The EpiVax team had a great time in Tokyo hosting the Westin Immunogenicity Seminar! Please see pictures from the event below. Stay tuned for dates/details for 2023! The EpiVax team is pleased to share a new date for the 14th Annual Westin Tokyo Seminar, Friday...
